Whether the reparative effects of fucoxanthin on the FFA-induced NAFLD cell model are related to FAS, SREBP-1c protein, Nrf2, and TLR4 pathways, however, remains unclear. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.